Boehringer Ingelheim Pharmaceuticals, Inc.: Drug Recall

Recall #D-0600-2021 · 05/04/2021

Class II: Risk

Recall Details

Recall Number: D-0600-2021
Classification: Class II
Product Type: Drug
Recalling Firm: Boehringer Ingelheim Pharmaceuticals, Inc.
Status: Terminated
Date Initiated: 05/04/2021
Location: Ridgefield, CT, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 15,198 bottles (30 tablets per bottle)

Reason for Recall

Subpotent Drug

Product Description

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

Distribution Pattern

AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR

Other Recalls by Boehringer Ingelheim Pharmaceuticals, Inc.

Class II: Risk 03/09/2023

Labeling: Label Mix-up

View all recalls by Boehringer Ingelheim Pharmaceuticals, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.